Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Scheuba

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Endocrinology|May 20, 2025
Locally advanced pheochromocytoma/paraganglioma exhibit high metastatic recurrence and disease specific mortality rates: long-term follow-up of 283 patientsWolfgang Raber, Andreas Scheuba, Rodrig Marculescu, et al.
Cancers|December 11, 2025
Metastatic Pheochromocytoma/Paraganglioma: Diagnostic Performance of Functional Imaging (<sup>18</sup>F-Fluoro-L-DOPA-, <sup>68</sup>Ga-DOTA- and <sup>18</sup>F-Fluoro-Deoxyglucose-Based PET/CT) and of <sup>123</sup>I-MIBG Scintigraphy in 57 Patients and 527 Controls During Long-Term Follow-UpAndreas Scheuba, Oana Cristina Kulterer, Reinhard Lehner, et al.
International Journal of Surgery (London, England)|March 31, 2023
MetAAA trial patients show superior quality of life compared to patients under regular surveillance for small AAA: a single-center retrospective cohort studyJohannes Klopf, Robin Willixhofer, Andreas Scheuba, et al.
International Journal of Cardiology|December 28, 2020
Polymorphisms in the IL-6 and TNF-α gene are associated with an increased risk of abdominal aortic aneurysmAgnieszka Jabłońska, Branislav Zagrapan, Christoph Neumayer, et al.
Medical Sciences (Basel, Switzerland)|November 24, 2025
MetAAA Trial Patients Receiving Metformin Therapy Show Limited Improvement in Quality of Life Compared to AAA Patients with Placebo Intake-A Double-Blind, Randomized, and Placebo-Controlled TrialJohannes Klopf, Robin Willixhofer, Diana Ahmadi-Fazel, et al.
The British Journal of Surgery|December 1, 2021
Growth prediction model for abdominal aortic aneurysmsRobin Ristl, Johannes Klopf, Andreas Scheuba, et al.
Frontiers in Endocrinology|September 5, 2024
Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patientsWolfgang Raber, Raphael Schendl, Melisa Arikan, et al.
International Journal of Surgery (London, England)|July 4, 2023
Comparing maximum diameter and volume when assessing the growth of small abdominal aortic aneurysms using longitudinal CTA data: cohort studyRobin Ristl, Johannes Klopf, Andreas Scheuba, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|May 1, 2025
Metformin to Inhibit Progression of Abdominal Aortic Aneurysm: A Randomised, Placebo Controlled Clinical TrialWolf Eilenberg, Johannes Klopf, Anna Sotir, et al.
Journal of Cardiovascular Translational Research|December 17, 2020
Complement Factor C5a Is Increased in Blood of Patients with Abdominal Aortic Aneurysm and Has Prognostic Potential for Aneurysm GrowthBranislav Zagrapan, Wolf Eilenberg, Andreas Scheuba, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Endocrinology|May 20, 2025
Locally advanced pheochromocytoma/paraganglioma exhibit high metastatic recurrence and disease specific mortality rates: long-term follow-up of 283 patientsWolfgang Raber, Andreas Scheuba, Rodrig Marculescu, et al.
Cancers|December 11, 2025
Metastatic Pheochromocytoma/Paraganglioma: Diagnostic Performance of Functional Imaging (<sup>18</sup>F-Fluoro-L-DOPA-, <sup>68</sup>Ga-DOTA- and <sup>18</sup>F-Fluoro-Deoxyglucose-Based PET/CT) and of <sup>123</sup>I-MIBG Scintigraphy in 57 Patients and 527 Controls During Long-Term Follow-UpAndreas Scheuba, Oana Cristina Kulterer, Reinhard Lehner, et al.
International Journal of Surgery (London, England)|March 31, 2023
MetAAA trial patients show superior quality of life compared to patients under regular surveillance for small AAA: a single-center retrospective cohort studyJohannes Klopf, Robin Willixhofer, Andreas Scheuba, et al.
International Journal of Cardiology|December 28, 2020
Polymorphisms in the IL-6 and TNF-α gene are associated with an increased risk of abdominal aortic aneurysmAgnieszka Jabłońska, Branislav Zagrapan, Christoph Neumayer, et al.
Medical Sciences (Basel, Switzerland)|November 24, 2025
MetAAA Trial Patients Receiving Metformin Therapy Show Limited Improvement in Quality of Life Compared to AAA Patients with Placebo Intake-A Double-Blind, Randomized, and Placebo-Controlled TrialJohannes Klopf, Robin Willixhofer, Diana Ahmadi-Fazel, et al.
The British Journal of Surgery|December 1, 2021
Growth prediction model for abdominal aortic aneurysmsRobin Ristl, Johannes Klopf, Andreas Scheuba, et al.
Frontiers in Endocrinology|September 5, 2024
Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patientsWolfgang Raber, Raphael Schendl, Melisa Arikan, et al.
International Journal of Surgery (London, England)|July 4, 2023
Comparing maximum diameter and volume when assessing the growth of small abdominal aortic aneurysms using longitudinal CTA data: cohort studyRobin Ristl, Johannes Klopf, Andreas Scheuba, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|May 1, 2025
Metformin to Inhibit Progression of Abdominal Aortic Aneurysm: A Randomised, Placebo Controlled Clinical TrialWolf Eilenberg, Johannes Klopf, Anna Sotir, et al.
Journal of Cardiovascular Translational Research|December 17, 2020
Complement Factor C5a Is Increased in Blood of Patients with Abdominal Aortic Aneurysm and Has Prognostic Potential for Aneurysm GrowthBranislav Zagrapan, Wolf Eilenberg, Andreas Scheuba, et al.
Pageof 2